Whole-genome Fingerprint of the DNA Methylome During Human B Cell Differentiation
Authors
Affiliations
We analyzed the DNA methylome of ten subpopulations spanning the entire B cell differentiation program by whole-genome bisulfite sequencing and high-density microarrays. We observed that non-CpG methylation disappeared upon B cell commitment, whereas CpG methylation changed extensively during B cell maturation, showing an accumulative pattern and affecting around 30% of all measured CpG sites. Early differentiation stages mainly displayed enhancer demethylation, which was associated with upregulation of key B cell transcription factors and affected multiple genes involved in B cell biology. Late differentiation stages, in contrast, showed extensive demethylation of heterochromatin and methylation gain at Polycomb-repressed areas, and genes with apparent functional impact in B cells were not affected. This signature, which has previously been linked to aging and cancer, was particularly widespread in mature cells with an extended lifespan. Comparing B cell neoplasms with their normal counterparts, we determined that they frequently acquire methylation changes in regions already undergoing dynamic methylation during normal B cell differentiation.
Glaser S, Fischer A, Martinez-Manjon J, Lopez C, Kretzmer H, Burkhardt B Leukemia. 2025; .
PMID: 40065077 DOI: 10.1038/s41375-025-02533-6.
Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk.
Aldakheel F, Alnajran H, Alduraywish S, Mateen A, AlQahtani M, Syed R Discov Oncol. 2025; 16(1):110.
PMID: 39893332 PMC: 11787142. DOI: 10.1007/s12672-025-01833-8.
Progress Toward Epigenetic Targeted Therapies for Childhood Cancer.
Liapodimitri A, Tetens A, Craig-Schwartz J, Lunsford K, Skalitzky K, Koldobskiy M Cancers (Basel). 2025; 16(24.
PMID: 39766049 PMC: 11674401. DOI: 10.3390/cancers16244149.
Navigating Illumina DNA methylation data: biology versus technical artefacts.
Glaser S, Kretzmer H, Kolassa I, Schlesner M, Fischer A, Fenske I NAR Genom Bioinform. 2024; 6(4):lqae181.
PMID: 39703427 PMC: 11655293. DOI: 10.1093/nargab/lqae181.
Charalampopoulou S, Chapiro E, Nadeu F, Zenz T, Bea S, Martinez-Farran A Blood Adv. 2024; 8(24):6297-6307.
PMID: 39471431 PMC: 11700275. DOI: 10.1182/bloodadvances.2024013327.